IDSA on X: New in CID: A #dengue vaccine candidate was efficacious against symptomatic dengue in children and adolescents over 3 years post-vaccination across 8 endemic countries. 📄: #IDSAJournals #ClinInfectDis
Por um escritor misterioso
Descrição
Frontiers Anti-dengue Vaccines: From Development to Clinical Trials
Efficacy profile of the CYD-TDV dengue vaccine revealed by
Dengue – the Region of the Americas
Opportunities for improved surveillance and control of dengue from
Host immunity and vaccine development against Dengue virus
Opportunities for improved surveillance and control of dengue from
Dengue Vaccine: Considerations before Rollout in Colombia
Dengvaxia Dengue Vaccine — Precision Vaccinations News
Four-year safety follow-up of the tetravalent dengue vaccine
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of
Current Status of Vaccines against Dengue Virus
Four-year safety follow-up of the tetravalent dengue vaccine
de
por adulto (o preço varia de acordo com o tamanho do grupo)
